Multicare Research Institute

Tacoma, Washington 98405

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Gastrointestinal Dysmotility, High Cardiovascular Risk, Obesity, Overweight, Tumors With CDK4/6 Pathway Activation, Type 2 Diabetes

Studies at this site

• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Ulimorelin Study of Efficacy and Safety (ULISES 008) — Completed